Related Experiment Video
Updated: Dec 3, 2025

09:48
An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
8.4K
PET Parameters are Useful in Predicting Endometrial Cancer Risk Classes and Prognosis
Adnan Budak1, Emrah Beyan1, Abdurrahman Hamdi Inan1
1Department of Obstetrics and Gynecology, Izmir Tepecik Training and Research Hospital, Izmir, Turkey.
Nuklearmedizin. Nuclear Medicine
|October 26, 2020
Summary
Preoperative PET scan parameters, particularly metabolic tumor volume (MTV) and total lesion glycolysis (TLG), help differentiate endometrial cancer (EC) risk groups and predict overall survival (OS). These imaging biomarkers offer valuable insights for patient management.
Area of Science:
- Oncology
- Nuclear Medicine
- Medical Imaging
Background:
- Endometrial cancer (EC) risk stratification is crucial for treatment planning.
- Accurate prognostic markers are needed to guide clinical decisions.
- Preoperative imaging can potentially provide non-invasive risk assessment.
Purpose of the Study:
- To evaluate the role of preoperative F-18 FDG PET/CT parameters in determining risk classes for endometrial cancer (EC).
- To assess the predictive value of PET parameters for the overall survival (OS) of EC patients.
Main Methods:
- 81 EC patients underwent preoperative F-18 FDG PET/CT.
- PET parameters (SUVmax, SUVmean, MTV, TLG) and clinicopathological factors were analyzed.
- Correlation between PET parameters, risk factors, and OS was investigated.
Main Results:
- Volumetric PET parameters (MTV, TLG) were significantly higher in high-risk EC patients.
- MTV and TLG showed strong discriminatory power for risk stratification (AUC > 0.83).
- MTV and TLG independently predicted overall survival (OS) in EC patients.
Conclusions:
- Preoperative PET parameters, especially MTV and TLG, effectively differentiate EC risk groups non-invasively.
- Volumetric PET parameters serve as independent predictors of overall survival in endometrial cancer.
Related Concept Videos
Cancer Survival Analysis
555
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
555
Kaplan-Meier Approach
436
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
436

